This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hangzhou Calibra Diagnostics Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Jinfei Ma in Primary Aldosteronism Diagnosis
Introduction
Jinfei Ma is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of primary aldosteronism. His innovative work has led to the development of a unique screening kit and diagnosis system that enhances the accuracy and efficiency of medical testing.
Latest Patents
Jinfei Ma holds a patent for a screening kit and diagnosis system for primary aldosteronism. This system utilizes a sample that is pretreated with a magnetic bead bonded with a balanced hydrophilic-lipophilic polymer. The process conditions are optimized to accurately detect the content of five markers, including aldosterone, using liquid chromatography-tandem mass spectrometry. The system establishes an optimal screening cut-off value of 20.4, allowing for the confirmation of primary aldosteronism and subsequent typing diagnosis based on test values. This integrated approach provides a reliable laboratory examination basis for clinicians to formulate effective therapeutic regimens.
Career Highlights
Jinfei Ma is associated with Hangzhou Calibra Diagnostics Co., Ltd., where he continues to innovate in the field of diagnostics. His work has not only advanced the understanding of primary aldosteronism but has also contributed to the development of more effective diagnostic tools.
Collaborations
Jinfei Ma collaborates with talented individuals such as Ziqing Kong and Pengyun Liu. Their combined expertise enhances the research and development efforts at Hangzhou Calibra Diagnostics Co., Ltd.
Conclusion
Jinfei Ma's contributions to the field of medical diagnostics, particularly through his patent for a screening kit and diagnosis system for primary aldosteronism, demonstrate his commitment to improving healthcare outcomes. His innovative work continues to pave the way for advancements in diagnostic technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile